| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 41.38B | 37.99B | 32.50B | 29.90B | 23.56B | 17.47B |
| Gross Profit | 13.58B | 12.81B | 10.80B | 8.70B | 6.96B | 5.44B |
| EBITDA | 9.98B | 8.89B | 7.37B | 5.76B | 4.90B | 3.27B |
| Net Income | 6.48B | 6.04B | 5.73B | 4.21B | 3.59B | 2.34B |
Balance Sheet | ||||||
| Total Assets | 41.49B | 41.49B | 31.50B | 28.13B | 23.93B | 19.93B |
| Cash, Cash Equivalents and Short-Term Investments | 7.34B | 8.00B | 7.08B | 4.98B | 3.22B | 4.48B |
| Total Debt | 4.62B | 4.42B | 3.39B | 4.01B | 2.11B | 1.97B |
| Total Liabilities | 18.08B | 18.36B | 13.64B | 12.89B | 9.92B | 8.00B |
| Stockholders Equity | 22.41B | 22.20B | 17.34B | 14.83B | 13.60B | 11.56B |
Cash Flow | ||||||
| Free Cash Flow | 4.33B | 5.40B | 5.36B | 1.81B | 92.04M | 3.37B |
| Operating Cash Flow | 6.82B | 7.25B | 7.02B | 2.98B | 939.38M | 3.93B |
| Investing Cash Flow | -3.07B | -4.09B | -1.71B | -1.35B | -683.87M | 207.38M |
| Financing Cash Flow | -2.65B | -2.76B | -2.96B | 191.91M | -1.44B | -2.36B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $28.49B | 12.77 | 15.88% | 1.04% | -5.24% | 45.69% | |
76 Outperform | $41.76B | 36.01 | 29.08% | 1.85% | 5.17% | -3.66% | |
75 Outperform | $17.68B | 27.41 | 17.97% | 0.96% | 0.83% | -1.32% | |
71 Outperform | $47.27B | 54.84 | 24.24% | 1.33% | 0.98% | -7.51% | |
69 Neutral | $34.29B | 64.38 | 5.35% | 0.10% | 4.20% | -34.47% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | $35.30B | 26.69 | ― | 1.88% | 0.73% | -15.57% |